HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elisa Izquierdo Selected Research
Elisa Izquierdo Research Topics
Disease
6
Neoplasms (Cancer)
10/2022 - 10/2017
2
Rhabdomyosarcoma
10/2022 - 01/2022
2
Glioma (Gliomas)
01/2021 - 01/2018
1
Diffuse Intrinsic Pontine Glioma
01/2022
1
Starvation
01/2022
1
Disease Progression
01/2021
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
10/2022 - 11/2019
2
Circulating Tumor DNA
IBA
10/2022 - 01/2021
2
DNA (Deoxyribonucleic Acid)
IBA
10/2022 - 01/2021
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2022
1
Type 4 Fibroblast Growth Factor Receptor
IBA
01/2022
1
Culture Media
IBA
01/2022
1
infigratinib
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
nintedanib
IBA
01/2022
1
ponatinib
IBA
01/2022
1
dipinacoline glutamate
IBA
01/2022
1
Mitogen-Activated Protein Kinases
IBA
01/2022
1
Ligands
IBA
01/2022
1
4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- one
IBA
01/2022
1
Cell-Free Nucleic Acids
IBA
01/2021
1
Phosphotransferases (Kinase)
IBA
01/2020
1
Temozolomide (Temodar)
FDA Link
Generic
01/2018
1
Bevacizumab (Avastin)
FDA Link
01/2018
1
Histones (Histone)
IBA
10/2017
Therapy/Procedure
2
Therapeutics
01/2022 - 01/2020
1
Operative Surgical Procedures
01/2021
1
Precision Medicine
11/2019
1
Radiotherapy
01/2018